Interestingly, a recent study has indicated that dapagliflozin can improve β cell function in a mouse model of T2DM, which might be partly due to its regulatory role in the PI3K-Akt axis [36]. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.